Trial
NCT00748566
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Schizophrenia and Disorders With Psychotic Features
Intervention
Ziprasidone HCL (oral)
Why stopped
See Detailed Description
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-03